Evidence map›Paper›PMID 31652356›Full record

ArticlePrenatal diagnosis2020

The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening.

Victoria K Berger, Mary E Norton, Teresa N Sparks, Monica Flessel, Rebecca J Baer, Robert J Currier

Open access · greenAbstract read
In one paragraph

Article in Prenatal diagnosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Victoria K BergerDivision of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA.ORCID 0000-0003-4347-6140
Mary E NortonDivision of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA.
Teresa N SparksDivision of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA.ORCID 0000-0002-8593-2186
Monica FlesselGenetic Disease Screening Program, California Department of Public Health, Richmond, CA.
Rebecca J BaerDepartment of Pediatrics, University of California, San Diego, CA.
Robert J CurrierDepartment of Pediatrics, University of California, San Francisco, CA.
University of California, San Francisco · USCalifornia Department of Public Health · USUniversity of California San Diego · US

Funding

WOMEN'S REPRODUCTIVE HEALTH RESEARCH CENTERK12HD001262 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Andrea Vashti Jackson · 1998 to 2026
$9.3M
NICHD NIH HHS K12 HD001262
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AneuploidyNoninvasive Prenatal TestingNuchal Translucency MeasurementAbnormal KaryotypeAdultCell-Free Nucleic AcidsChromosome AberrationsDown SyndromeFemaleHumansKaryotypingPredictive Value of TestsPregnancyRare DiseasesRetrospective StudiesSensitivity and SpecificityCell-Free Nucleic Acids

Identifiers

PMID31652356
PMCPMC7002253
OpenAlexW2982285038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.